128 research outputs found
Classification Framework and Structure-Activity-Relationship (SAR) of Tetracycline-Structure-Based Drugs
By studying the literature about Tetracyclines (TCs), it becomes clearly
evident that TCs are very dynamic molecules. In some cases, their
structure-activity-relationship (SAR) are known, especially against bacteria,
while against other targets, they are virtually unknown. In other diverse
yields of research, such as neurology, oncology and virology the utility and
activity of the tetracyclines are being discovered and are also emerging as new
technological fronts. The first aim of this paper is classify the compounds
already used in therapy and prepare the schematic structure in which include
the next generation of TCs. The aim of this work is introduce a new framework
for the classification of old and new TCs, using a medicinal chemistry approach
to the structure of that drugs. A fully documented
Structure-Activity-Relationship (SAR) is presented with the analysis data of
antibacterial and nonantibacterial (antifungal, antiviral and anticancer)
tetracyclines. Lipophilicity of functional groups and conformations
interchangeably are determining rules in biological activities of TCs.Comment: 13 pages, 3 figures, 2 schemes, 1 table;
http://www.mdpi.com/2079-6382/1/1/
Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study
BACKGROUND: Insulin is the recommend therapeutic agent of choice for the management of Cystic Fibrosis Related Diabetes (CFRD), despite only sub-optimal reductions in glycemic control and increased morbidity and mortality reported by centers using this agent. The newer insulin sensitizing agents demonstrated to have anti-inflammatory mechanisms may provide an alternative management option for CFRD. METHODS: A prospective case based therapeutic comparison between insulin, sulfonylurea, metformin and thiazolidinedione was observed over one decade with 20 CFRD patients diagnosed using American Diabetes Association guideline standards. Patients entering the study elected treatment based on risk and benefit information provided for treatment options. Patients receiving organ transplant or requiring combination diabetic medications were excluded from the study. RESULTS: No statistical advantage was achieved regarding overall glycemic control for oral agents over insulin. Additional outcome measures including changes in weight, liver function testing and FEV(1 )were not statistically significant. CONCLUSION: Insulin alone may not be the only therapeutic option in managing CFRD. Oral hypoglycemic agents were equally effective in treating CFRD and may provide an alternative class of agents for patients reluctant in using insulin
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities
Cystic fibrosis (CF) patients suffer from chronic bacterial lung infections that lead to death in the majority of cases. The need to maintain lung function in these patients means that characterising these infections is vital. Increasingly, culture-independent analyses are expanding the number of bacterial species associated with CF respiratory samples; however, the potential significance of these species is not known. Here, we applied ecological statistical tools to such culture-independent data, in a novel manner, to partition taxa within the metacommunity into core and satellite species. Sputa and clinical data were obtained from 14 clinically stable adult CF patients. Fourteen rRNA gene libraries were constructed with 35 genera and 82 taxa, identified in 2139 bacterial clones. ShannonβWiener and taxa-richness analyses confirmed no undersampling of bacterial diversity. By decomposing the distribution using the ratio of variance to the mean taxon abundance, we partitioned objectively the species abundance distribution into core and satellite species. The satellite group comprised 67 bacterial taxa from 33 genera and the core group, 15 taxa from 7 genera (including Pseudomonas (1 taxon), Streptococcus (2), Neisseria (2), Catonella (1), Porphyromonas (1), Prevotella (5) and Veillonella (3)], the last four being anaerobes). The core group was dominated by Pseudomonas aeruginosa. Other recognised CF pathogens were rare. Mantel and partial Mantel tests assessed which clinical factors influenced the composition observed. CF transmembrane conductance regulator genotype and antibiotic treatment correlated with all core taxa. Lung function correlated with richness. The clinical significance of these core and satellite species findings in the CF lung is discussed
Pseudomonas aeruginosa isolates: Comparisons of isolates from campers and from sibling pairs with cystic fibrosis
CYSTIC FIBROSIS1 1Formerly known as Mucoviscidosis or Fibrocystic Disease of the Pancreas. 2 2Delivered at the XI Biennial Congress of the A.P.A., Adelaide, August, 1969.
- β¦